It has been reported that depot drug formulations for controlled release of pharmaceutical
drugs may be prepared using alginates alone (see US Pat. No. 5,132,295), using …

A buoyant controlled release pharmaceutical powder formulation is provided which may be?
lled into cap sules and releases a pharmaceutical of a basic character at a controlled rate …

The present invention provides for reduced daily dosing of poorly soluble basic drugs by
applying the alginate matrix with the incorporation of an organic acid. A basic drug's …

[57] ABSTRACT A controlled release pharmaceutical formulation is pro vided which
releases a pharmaceutical of a basic char acter at a controlled rate regardless of the pH of …

A pH-dependent sustained release, drug delivery composition capable of being formed into
tablets or pellets, wherein the release is controlled by a diffusion barrier formed by the …

A solid, controlled release pharmaceutical composition is provided with enhanced levels of
control over drug release. The composition comprises an acid addition salt or a quarternary …

Verapamil depot drug formulations include the pharmaceutical itself and a three component
release rate controlling matrix composition. The three components of the matrix composition …

VALLEY FORGE, PA 19482-0980 (US) The disclosed invention is a method and
composition for improving the bioavailability of a pharmaceutically active (21) Appl. No …

The advantages of controlled release products are well known in the pharmaceutical field
and include the ability to maintain a desired blood level of a medicament over a …

Pharmaceutical formulations are disclosed, adapted for preparing solid oral dosage forms
(tablets, capsules, lozenges, etc.) having a regular and sustained release after …